Centenario Hospital Miguel Hidalgo Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2019
NCT04545892
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centenario Hospital Miguel Hidalgo

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5